76350957 - SCIENION

Information

• Trademark
• 76350957

• Source

• Serial Number

  76350957

• Registration Number

  3152451

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 20, 2001
  22 years ago

• Registration Date

  October 10, 2006
  17 years ago

• Transaction Date

  April 06, 2017
  7 years ago

• Status Date

  January 13, 2017
  7 years ago

• Published for Opposition Date

  December 28, 2004
  19 years ago

• Renewal Date

  October 10, 2016
  7 years ago

• Location Date

  January 13, 2017
  7 years ago

• Status Code

  800

• Current Location

  GENERIC WEB UPDATE

  Employee Name

  MCMORROW, RONALD G

• Attorney Docket Number

  030265-1036-

  Attorney Name

  Jeffrey H. Brown

  Law Office Assigned Location Code

  L50

• Owners

  • SCIENION AG

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Chemical products for industrial and scientific purposes, namely, nucloic acids, peptides and proteins for scientific and research use in the fields of phannacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; libraries of immobilized chemical compounds for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; arrays of chemical compounds, namely, nucleic acids, peptides and proteins for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; arrays of libraries of chemical compounds arranged on a support for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; chemical compounds produced by using immobilized chemical compounds, libraries of chemical compounds and arrays of chemical compounds, namely, such compounds which are immobilized on a support for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research
• GS0051: [ Pharmaceutical and veterinary products, namely, antiseptics, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirheumatic drags, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolyrics, hemostatics, antihypertonics, antihypoglycemics, antihypotonica, anlicoagulauts, antimycotics, pharmaceuticals functioning as antiparasitics, antiphiogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin system, pharmaceuticals functioning as broncholytics, antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disirifectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastro-ititestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies for use in the treatment of salmonellosis, paratuberculosis and cancer; veterinary preparations for use in the treatment of diseases equivalent to salnionellosis, paratubeculosis and cancer; pharmaceutical and veterinary products, namely, antiseptics, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirhsuinatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antlinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics; antiepileptics, antihermorrhagics, antifibrinolyrics, hemostatic; antihypertonics, antihypoglycomics, antihypotonica, anticoagulant; antimycotics, pharmaceuticals functioning as antiparasitics, antiphiogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensinir system, pharmaceuticals functioning as broncholytics, antiastlimetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfeetants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastro- intestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, daoryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologica and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies far use in the treatment of salmonellosis, paratubereulosis and cancer; arrays of libraries of chemical compounds arranged on a support for clinical or medical laboratory use; chemical compounds arranged on a support for clinical or medical laboratory use; nutraceuticals for use in dietary supplements ]
• GS0091: Scientific measure and controlling apparatus and instruments; support materials, more particularly membranes and glass; scientific instruments and devices comprising support materials, more particularly membranes and glass, comprising chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, comprising immobilized chemical compounds, comprising libraries of chemical compounds for industrial and scientific purposes, more particularly immobilized chemical compounds for industrial and scientific purposes, comprising arrays of chemical compounds, more particularly of nucleic acids, peptides and proteins, comprising arrays of libraries of chemical compounds, more particularly libraries of chemical compounds arranged on a support, comprising compounds produced by using or by means of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such chemical compounds which are immobilized on a support, comprising chemical compounds for industrial and scientific purposes manufactured by using or by means of chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins; computer software and programs, more particularly computer programs for synthesis and/or immobilization of chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, of immobilized chemical compounds, of arrays of libraries of chemical compounds, more particularly arrays of chemical compounds arranged on a support, of compounds manufactured with the aid of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such compounds which are immobilized on a support; computer software (saved), computer programs, more particularly computer programs for analysis of patterns of surfaces, more particularly of support materials like membranes and glass, more particularly such supports comprising chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, for analysis of immobilized chemical compounds, for analysis of chemical compounds for industrial and scientific purposes, for analysis of arrays of chemical compounds, more particularly of nucleic acids, peptides and proteins, for analysis of arrays of libraries of chemical compounds, more particularly libraries of chemical compounds arranged on a support, for analysis of compounds manufactured with the aid of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such compounds which are immobilized on a support; programs, more particularly computer programs, for screening of compounds such as nucleic acids, peptides and proteins; software for picture evaluation; and software for data evaluation; apparatus and apparatus for analysis for use in synthesis and/or immobilization of chemical products for industrial and scientific purposes, for production and analysis of patterns of surfaces and for screening of compounds such as nucleic acids, peptides and proteins, more particularly such apparatus and apparatus for analysis with integrated data analysis; diagnostic apparatus and analysis apparatus for synthesis and/or immobilization of chemical products for industrial and scientific purposes, for production and analysis of patterns of/on surfaces and for screening of compounds such as nucleic acids, peptides and proteins, more particularly such apparatus and analysis apparatus with integrated data analysis; chambers, more particularly chambers for hybridization; spotting apparatus
• GS0401: Custom chemical synthesis for others, namely, synthesis of nucleic acids, peptides, and proteins for industrial and scientific purposes, synthesis of immobilized chemical compounds, arrays, and libraries of nucleic acids, peptides and proteins for industrial and scientific purposes; immobilization of chemical products for others, namely, immobilization of nucleic acids, peptides, and proteins for industrial and scientific purposes, immobilization of arrays and libraries of nucleic acids, peptides and proteins for industrial and scientific purposes; custom manufacture, spotting, and design of biochips for others
• GS0421: Product research and development in the fields in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology, namely, products used in the synthesis and immobilization of chemical products for industrial and scientific purposes, products research and development in the field of synthesis and immobilization of arrays and arrays of libraries of chemical compounds arranged on a support; scientific research, namely, screening for chemical interaction partners; product research and development in the field of chemical screening for interaction partners; development of new diagnostic technology for others in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology; screening and development of arrays and libraries of arrays of immobilized chemical compounds arranged on a support for industrial and scientific purposes; development of computer software for use in screening and development of arrays and libraries of arrays of immobilized chemical compounds arranged on a support for industrial and scientific purposes; development of data processing software for use in product research and screening; database development and providing an on-line database in the field of product research and development in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology

Case File Event Statements

• 4/5/2017 - 7 years ago

  52 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/13/2017 - 7 years ago

  51 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89

• 1/13/2017 - 7 years ago

  50 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1

• 1/13/2017 - 7 years ago

  49 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG

• 1/10/2017 - 7 years ago

  48 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 9/7/2016 - 7 years ago

  47 - POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Type: PR89

• 9/6/2016 - 7 years ago

  46 - TEAS SECTION 8 & 9 RECEIVED Type: E89R

• 10/10/2015 - 8 years ago

  45 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 3/15/2013 - 11 years ago

  44 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 3/15/2013 - 11 years ago

  43 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 3/1/2013 - 11 years ago

  42 - REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Type: 815F

• 3/15/2013 - 11 years ago

  41 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 3/1/2013 - 11 years ago

  40 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 12/22/2011 - 12 years ago

  39 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/3/2010 - 14 years ago

  38 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA

• 2/3/2010 - 14 years ago

  37 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP

• 10/24/2007 - 16 years ago

  36 - REVIEW OF CORRESPONDENCE COMPLETE Type: CORV

• 10/19/2007 - 16 years ago

  35 - PAPER RECEIVED Type: MAIL

• 10/10/2006 - 17 years ago

  34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/25/2006 - 17 years ago

  33 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B

• 8/25/2006 - 17 years ago

  32 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 8/8/2006 - 17 years ago

  31 - PAPER RECEIVED Type: MAIL

• 3/6/2006 - 18 years ago

  30 - EXTENSION 2 GRANTED Type: EX2G

• 3/6/2006 - 18 years ago

  29 - EXTENSION 2 FILED Type: EXT2

• 3/6/2006 - 18 years ago

  28 - TEAS EXTENSION RECEIVED Type: EEXT

• 12/21/2005 - 18 years ago

  27 - UNDELIVERABLE MAIL - NO ACTION TAKEN Type: UNDN

• 12/6/2005 - 18 years ago

  26 - PAPER RECEIVED Type: MAIL

• 12/1/2005 - 18 years ago

  25 - EXTENSION 1 GRANTED Type: EX1G

• 9/22/2005 - 18 years ago

  24 - EXTENSION 1 FILED Type: EXT1

• 11/16/2005 - 18 years ago

  23 - PETITION TO REVIVE-GRANTED Type: PETG

• 10/4/2005 - 18 years ago

  22 - PETITION TO REVIVE-RECEIVED Type: PETR

• 10/4/2005 - 18 years ago

  21 - PAPER RECEIVED Type: MAIL

• 3/22/2005 - 19 years ago

  20 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/28/2004 - 19 years ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/8/2004 - 19 years ago

  18 - NOTICE OF PUBLICATION Type: NPUB

• 10/19/2004 - 19 years ago

  17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 10/8/2004 - 19 years ago

  16 - ASSIGNED TO LIE Type: ALIE

• 10/6/2004 - 19 years ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/3/2004 - 19 years ago

  14 - PAPER RECEIVED Type: MAIL

• 6/18/2004 - 20 years ago

  13 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 6/18/2004 - 20 years ago

  12 - UNRESPONSIVE/DUPLICATE PAPER RECEIVED Type: UNPR

• 6/18/2004 - 20 years ago

  11 - PAPER RECEIVED Type: MAIL

• 2/4/2004 - 20 years ago

  10 - FINAL REFUSAL MAILED Type: CNFR

• 11/24/2003 - 20 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/18/2003 - 20 years ago

  8 - CASE FILE IN TICRS Type: CFIT

• 11/24/2003 - 20 years ago

  7 - PAPER RECEIVED Type: MAIL

• 5/22/2003 - 21 years ago

  6 - INQUIRY AS TO SUSPENSION MAILED Type: CNSI

• 11/7/2002 - 21 years ago

  5 - LETTER OF SUSPENSION MAILED Type: CNSL

• 9/27/2002 - 21 years ago

  4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/23/2002 - 21 years ago

  3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/28/2002 - 22 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 3/8/2002 - 22 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK